Skip to main content

Ani Pharmaceuticals Inc

ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001023024

In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Ani Pharmaceuticals Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of ANIP: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders172186+14
Shares12.3M13.2M+889.7K (+7.2%)
Value$662.5M$766.4M+$103.9M (+15.7%)

New holders (30)

Institutions that held Ani Pharmaceuticals Inc at the end of Q3 2023 but not at the end of Q2 2023.

Sold out (16)

Institutions that held Ani Pharmaceuticals Inc at the end of Q2 2023 and filed for Q3 2023 without it.